Vext Science, Inc.
VEXTF
$0.0943
$0.0022.17%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.40% | -1.04% | -2.40% | 1.07% | -1.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.40% | -1.04% | -2.40% | 1.07% | -1.69% |
| Cost of Revenue | 18.60% | 27.10% | 46.75% | 85.75% | 90.20% |
| Gross Profit | -25.33% | -39.92% | -54.44% | -56.73% | -48.63% |
| SG&A Expenses | -17.66% | 89.87% | 86.31% | 38.62% | 41.18% |
| Depreciation & Amortization | 44.61% | 60.79% | 85.45% | 59.68% | 39.91% |
| Other Operating Expenses | 2,068.42% | 94.44% | 41.67% | -116.67% | -253.23% |
| Total Operating Expenses | 11.41% | 48.19% | 63.39% | 65.01% | 63.28% |
| Operating Income | -46.82% | -2,294.33% | -538.45% | -304.12% | -184.88% |
| Income Before Tax | -728.13% | -33.20% | -528.82% | -217.96% | -49.79% |
| Income Tax Expenses | 226.77% | 116.79% | 109.38% | 96.56% | 75.46% |
| Earnings from Continuing Operations | -610.06% | -250.02% | -194.69% | -122.98% | -59.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -610.06% | -250.02% | -194.69% | -122.98% | -59.72% |
| EBIT | -46.82% | -2,294.33% | -538.45% | -304.12% | -184.88% |
| EBITDA | 90.59% | -122.12% | -133.64% | -107.63% | -90.39% |
| EPS Basic | -599.47% | -180.49% | -160.62% | -115.89% | -76.06% |
| Normalized Basic EPS | -40.70% | -246.81% | -55,000.00% | -458.59% | -210.61% |
| EPS Diluted | -609.63% | -185.71% | -164.41% | -120.31% | -74.70% |
| Normalized Diluted EPS | -40.82% | -245.39% | -54,900.00% | -457.81% | -210.29% |
| Average Basic Shares Outstanding | 46.41% | 56.84% | 43.40% | 29.44% | 18.48% |
| Average Diluted Shares Outstanding | 46.56% | 57.42% | 43.04% | 29.05% | 18.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |